The people administered with the Vero Cell vaccine against COVID-19 are found to have developed 72.4 percent antibody, more than those who have been administered Covishield.
A new study has revealed that the side effects of the Pfizer-BioNTech jab against COVID-19 in 12-15-year-olds at high risk of complications from the infection are likely to be mild to moderate and clear up quickly because of certain coexisting conditions.
